BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 26680494)

  • 21. Verifying Clinically Derived Reference Intervals for Daily Excretion Rates of Fractionated Metanephrines Using Modern Indirect Reference Interval Models.
    Doyle K; Frank EL
    Am J Clin Pathol; 2021 Sep; 156(4):691-699. PubMed ID: 33880513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma.
    Peitzsch M; Prejbisz A; Kroiß M; Beuschlein F; Arlt W; Januszewicz A; Siegert G; Eisenhofer G
    Ann Clin Biochem; 2013 Mar; 50(Pt 2):147-55. PubMed ID: 23512172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of plasma free metanephrines in diagnosis of pheochromocytomas and paragangliomas in the population of Asturias.
    Martínez-Morillo E; Valdés Gallego N; Eguia Ángeles E; Fernández Fernández JC; Prieto García B; Álvarez FV
    Endocrinol Diabetes Nutr (Engl Ed); 2019 May; 66(5):312-319. PubMed ID: 30391255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated
    Eisenhofer G; Prejbisz A; Peitzsch M; Pamporaki C; Masjkur J; Rogowski-Lehmann N; Langton K; Tsourdi E; Pęczkowska M; Fliedner S; Deutschbein T; Megerle F; Timmers HJLM; Sinnott R; Beuschlein F; Fassnacht M; Januszewicz A; Lenders JWM
    Clin Chem; 2018 Nov; 64(11):1646-1656. PubMed ID: 30097498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual-Template Magnetic Molecularly Imprinted Polymer for Simultaneous Determination of Spot Urine Metanephrines and 3-Methoxytyramine for the Diagnosis of Pheochromocytomas and Paragangliomas.
    Zeng H; Zhang X; Zhen Q; He Y; Wang H; Zhu Y; Sun Q; Ding M
    Molecules; 2022 May; 27(11):. PubMed ID: 35684457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma and urinary metanephrines determined by an enzyme immunoassay, but not serum chromogranin A for the diagnosis of pheochromocytoma in patients with adrenal mass.
    Unger N; Hinrichs J; Deutschbein T; Schmidt H; Walz MK; Mann K; Petersenn S
    Exp Clin Endocrinol Diabetes; 2012 Sep; 120(8):494-500. PubMed ID: 22696168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unilateral and bilateral adrenalectomy for pheochromocytoma requires adjustment of urinary and plasma metanephrine reference ranges.
    Osinga TE; van den Eijnden MH; Kema IP; Kerstens MN; Dullaart RP; de Jong WH; Sluiter WJ; Links TP; van der Horst-Schrivers AN
    J Clin Endocrinol Metab; 2013 Mar; 98(3):1076-83. PubMed ID: 23365125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of plasma methoxyamines for the diagnosis of pheochromocytoma.
    Mornex R; Peyrin L; Pagliari R; Cottet-Emard JM
    Horm Res; 1991; 36(5-6):220-6. PubMed ID: 1688051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Properly Collected Plasma Metanephrines Excludes PPGL After False-Positive Screening Tests.
    Kline GA; Boyd J; Polzin B; Harvey A; Pasieka JL; Sadrzadeh HSM; Leung AA
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e2900-e2906. PubMed ID: 33846745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
    Christensen TT; Frystyk J; Poulsen PL
    Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Random 'spot' urinary metanephrines compared with 24-h-urinary and plasma results in phaeochromocytomas and paragangliomas.
    Sbardella E; Maunsell Z; May CJH; Tadman M; James T; Jafar-Mohammadi B; Isidori AM; Grossman AB; Shine B
    Eur J Endocrinol; 2020 Aug; 183(2):129-139. PubMed ID: 32413848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of laboratory data of 155 patients with pheochromocytoma-paraganglioma syndrome diagnosed during the past 20 years].
    Balog B; Tőke J; Róna K; Szücs N; Igaz P; Pusztai P; Sármán B; Gláz E; Kiss R; Patócs A; Rácz K; Tóth M
    Orv Hetil; 2015 Apr; 156(16):626-35. PubMed ID: 25864138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A high sensitivity LC-MS/MS method for measurement of 3-methoxytyramine in plasma and associations between 3-methoxytyramine, metanephrines, and dopamine.
    Smy L; Kushnir MM; Frank EL
    J Mass Spectrom Adv Clin Lab; 2021 Aug; 21():19-26. PubMed ID: 34820673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simple, rapid, and cost-effective microextraction by the packed sorbent method for quantifying of urinary free catecholamines and metanephrines using liquid chromatography-tandem mass spectrometry and its application in clinical analysis.
    Xiong X; Zhang Y
    Anal Bioanal Chem; 2020 May; 412(12):2763-2775. PubMed ID: 32130439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different diagnostic cut-off values of urinary fractionated metanephrines according to sex for the diagnosis of pheochromocytoma in Korean subjects.
    Sohn SY; Park HD; Lee SY; Kim JH; Jung BC; Kim HJ; Jang HW; Kim KW; Lee MK; Min YK; Kim JH
    Endocr J; 2012; 59(9):831-8. PubMed ID: 22785075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma free metanephrines for diagnosis of neuroblastoma patients.
    Barco S; Verly I; Corrias MV; Sorrentino S; Conte M; Tripodi G; Tytgat G; van Kuilenburg A; van der Ham M; de Sain-van der Velden M; Garaventa A; Cangemi G
    Clin Biochem; 2019 Apr; 66():57-62. PubMed ID: 30822416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ACCURACY OF PLASMA FREE METANEPHRINES IN THE DIAGNOSIS OF PHEOCHROMOCYTOMA AND PARAGANGLIOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Chen Y; Xiao H; Zhou X; Huang X; Li Y; Xiao H; Cao X
    Endocr Pract; 2017 Oct; 23(10):1169-1177. PubMed ID: 28704098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
    Rao D; Peitzsch M; Prejbisz A; Hanus K; Fassnacht M; Beuschlein F; Brugger C; Fliedner S; Langton K; Pamporaki C; Gudziol V; Stell A; Januszewicz A; Timmers HJLM; Lenders JWM; Eisenhofer G
    Eur J Endocrinol; 2017 Aug; 177(2):103-113. PubMed ID: 28476870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical utility of chromogranin A in SDHx-related paragangliomas.
    Zuber S; Wesley R; Prodanov T; Eisenhofer G; Pacak K; Kantorovich V
    Eur J Clin Invest; 2014 Apr; 44(4):365-71. PubMed ID: 24467715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors.
    Procopiou M; Finney H; Akker SA; Chew SL; Drake WM; Burrin J; Grossman AB
    Eur J Endocrinol; 2009 Jul; 161(1):131-40. PubMed ID: 19383804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.